Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

# AGENCY:

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

# ACTION:

Notice; correction.

# SUMMARY:

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces an amendment to the following meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC). The meeting is open to the public.

# FOR FURTHER INFORMATION CONTACT:

                        Sydnee Byrd, M.P.A., Program Analyst, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027. Telephone: (404) 718-8039; Email:                         *HICPAC@cdc.gov.*

# SUPPLEMENTARY INFORMATION:

## Correction

                    Notice is hereby given of a change in the meeting of the Healthcare Infection Control Practices Advisory Committee; November 14, 2024, from 9 a.m. to 5 p.m., EST, and November 15, 2024, from 9 a.m. to 12 p.m., EST, in the original                     **Federal Register**                     notice.                

                    Notice of the virtual meeting was published in the                     **Federal Register**                     on October 17, 2024, 89 FR 83688.                

The meeting notice is being amended to update the dates section; addresses section; and supplementary information section, including the addition of instructions for providing written public comment. These sections should read as follows:

**DATES:**                     The meeting will be held on November 14, 2024, from 8 a.m. to 5:45 p.m., EST, and November 15, 2024, from 8 a.m. to 12:30 p.m., EST.                

**ADDRESSES:**                     The meeting will be webcast live via the World Wide Web. The webcast link can be found on the HICPAC website at                     *https://www.cdc.gov/​hicpac/​php/​upcoming-meeting/​index.html.*

**SUPPLEMENTARY INFORMATION:**

*Purpose:*                     The Healthcare Infection Control Practices Advisory Committee (HICPAC) is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion; the Director, National Center for Emerging and Zoonotic Infectious Diseases; the Director, Centers for Disease Control and Prevention (CDC); and the Secretary, Department of Health and Human Services, regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.                

*Matters to be Considered:*                     The agenda will include the following updates: the Division of Healthcare Quality Promotion; the Isolation Precautions Guideline Workgroup; and the Healthcare Personnel Guideline Workgroup. Agenda items are subject to change as priorities dictate.                

## Public Participation

*Oral Public Comment:*                     This meeting will include time for members of the public to make an oral comment. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. All persons interested in making an oral public comment at the November 14-15, 2024, HICPAC meeting must submit a request between October 15, 2024, and October 25, 2024, at                     *https://www.cdc.gov/​hicpac/​php/​upcoming-      ( print page 88282)    meeting/​index.html*                     no later than 5 p.m., EDT, on October 25, 2024, according to the instructions provided. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a random draw to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by November 1, 2024.                

*Written Public Comment:*                     Written comments should be submitted by email to                     *HICPAC@cdc.gov.*                     The deadline for receipt of written public comments is November 22, 2024. All submissions must contain the submitter's name, address, and organizational affiliation, as well as the topic being addressed. Written comments should not exceed one single-spaced typed page in length, not including attachments. All written comments will be shared with the Committee.                

                    The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign                     **Federal Register**                     notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                

Kalwant Smagh,

Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. 2024-25906 Filed 11-6-24; 8:45 am]

BILLING CODE 4163-18-P